Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 236, Issue 3, 1998, Pages 196-201

  Saika, Shizuya ^a   Yamanaka, Akifumi ^b   Yamanaka, Akio ^c   Minamide, Ayako ^a   Kin, Keisyu ^d   Shirai, Kumi ^a   Tanaka, Sai Ichi ^a   Kawashima, Yoshiji ^a   Katoh, Tadashi ^a   Okada, Yuka ^a   Ohkawa, Kiyomi ^a   Ohnishi, Yoshitaka ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c KOBE KAISEI HOSPITAL   (Japan)

^d Hashimoto Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA MACULA LUTEA; SUBRETINAL FLUID; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; DRAINAGE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; MALE; PLASMINOGEN ACTIVATORS; RETINA; RETINAL HEMORRHAGE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 6844241942     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050064     Document Type: Article

References (14)

1. Glatt H, Machemer R (1991) Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 94: 762-773
2. Hanscom TA, Diddie KR (1987) Early surgical drainage of macular subretinal hemorrhage. Arch Ophthalmol 105: 1722-1723
3. Hoylaerts M, Rijken DC, Lijnen HR, Collen D (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J Biol Chem 257: 2912-2919
4. Jaffe GJ, Abrams GW, Williams GA, Han DP (1990) Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology 97: 184-189
5. Johnson MW, Olsen KR, Hernandez E, Irvine D, Johnson RN (1990) Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 108: 259-263
6. Juan E de Jr, Machemer R (1988) Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration. Am J Ophthalmol 105: 25-29
7. Lewis H, Resnick SC, Flannery JG, Straatsma BR (1991) Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 111: 197-204
8. Macular Photocoagulation Study Group (1986) Argon laser photocoagulation for neovascular maculopathy: three-year results from randomized clinical trials. Arch Ophthalmol 104: 694-701
9. Okada Y, Shirai K, in K, Saika S, Ohnishi Y, Yamanaka A, Yamanaka A (1996) Application of a simple injector of tissue plasminogen activator into the subretinal hematoma. (in Japanese) Rinsho Ganka 50: 1258-1259
10. Peyman GA, Nelson NC Jr, Alturki W, Binder K, Paris CL, Desai UR, Harper CA III (1991) Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 22: 575-582
11. Shirai K, Okada Y, Kobata S, Saika S, Ohnishi Y, Yamanaka A, Yamanaka A (1996) Treatment of submacular hemorrhage secondary to retinal macroaneurysm by vitrectomy and tissue plasminogenactivator. (in Japanese) Rinsho Ganka 50: 1262-1264
12. Vender JF, Federman JL, Greven C, Slusher MM, Gabel V-P (1911) Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology 98: 23-27
13. Wade EC, Flynn HW Jr, Olsen KR, Blumenkranz MS, Nicholson DH (1990) Subretinal hemorrhage management by pars plana vitrectomy and internal drainage. Arch Ophthalmol 108: 973-978
14. Williams DF, Bennett SR, Abrams GW, Han DP, Mieler WF, Jaffe GJ, Williams GA (1990) Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation. Am J Ophthalmol 109: 606-607